 | Exelixis, Inc. | |||
| NMS : EXEL || Location: United States | ||||
$23.71+0.42 (+1.8%) |
1.63 M | 23.19 - 23.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 6.828 M |
| March 15, 2024 | 8.254 M |
| Feb. 29, 2024 | 8.854 M |
| Feb. 15, 2024 | 8.366 M |
| Jan. 31, 2024 | 7.309 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.22 | 0.27 | 24.60% |
| 06/30/2023 | 0.16 | 0.25 | 53.19% |
| 03/31/2023 | 0.15 | 0.12 | -20.58% |
| 12/31/2022 | -0.13 | -0.09 | 28.34% |
| 09/30/2022 | 0.19 | 0.23 | 21.10% |
EXEL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 294.800M | Shares Float | 254.407M |
| Short Float | 6.828M | Market Cap | 6989.71M |
| Institution ownership | 90.58% | Insider ownership | 2.235% |
| Earnings Date | 04/30/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.65 | Forward EPS | 1.47 |